Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Gender identity disorders and multiple sclerosis risk: A national record-linkage study.
Alerting Network Dysfunction in Early Multiple Sclerosis.
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.
Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes.
Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta™, for Multiple Sclerosis
Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study.
Glatiramer acetate ameliorates experimental autoimmune neuritis.
Emotional Change-Associated T Cell Mobilization at the Early Stage of a Mouse Model of Multiple Sclerosis.
Efficacy of remission-induction regimens for ANCA-associated vasculitis.
Oxidative modification of serum proteins in multiple sclerosis.
The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis.
Gait Mechanics are Different between Healthy Controls and Patients with Multiple Sclerosis.
Individual axons regulate the myelinating potential of single oligodendrocytes in vivo.
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
Mechanical environment modulates biological properties of oligodendrocyte progenitor cells.
Dose titration of BAF312 attenuates the initial heart rate reducing effect in healthy subjects.
Uhthoff's phenomena in MS-clinical features and pathophysiology.
Recurrent brainstem lesions mimicking infarctions in an elderly patient with neuromyelitis optica spectrum disorder.
Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide)
Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: Favorable response to cancer treatment.
Fatal toxic epidermal necrolysis in a patient on teriflunomide treatment for relapsing multiple sclerosis.

Pages